Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Viguié-Vallanet

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Annales De Dermatologie Et De Venereologie|July 28, 1999
[Tinea]C Viguié-Vallanet
Annales De Dermatologie Et De Venereologie|July 1, 2005
[Epidemic of Trichophyton tonsurans tinea capitis in a nursery school in the Southern suburbs of Paris]C Viguié-Vallanet, M Serre, L Masliah, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 26, 2006
Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled studyJ P Ortonne, H C Korting, C Viguié-Vallanet, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Annales De Dermatologie Et De Venereologie|July 28, 1999
[Tinea]C Viguié-Vallanet
Annales De Dermatologie Et De Venereologie|July 1, 2005
[Epidemic of Trichophyton tonsurans tinea capitis in a nursery school in the Southern suburbs of Paris]C Viguié-Vallanet, M Serre, L Masliah, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 26, 2006
Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled studyJ P Ortonne, H C Korting, C Viguié-Vallanet, et al.
Pageof 1